1. Home
  2. TBBK vs IOVA Comparison

TBBK vs IOVA Comparison

Compare TBBK & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBBK
  • IOVA
  • Stock Information
  • Founded
  • TBBK 1999
  • IOVA 2007
  • Country
  • TBBK United States
  • IOVA United States
  • Employees
  • TBBK N/A
  • IOVA N/A
  • Industry
  • TBBK Major Banks
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TBBK Finance
  • IOVA Health Care
  • Exchange
  • TBBK Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • TBBK 2.6B
  • IOVA 2.6B
  • IPO Year
  • TBBK 2004
  • IOVA N/A
  • Fundamental
  • Price
  • TBBK $56.13
  • IOVA $5.78
  • Analyst Decision
  • TBBK Buy
  • IOVA Strong Buy
  • Analyst Count
  • TBBK 3
  • IOVA 9
  • Target Price
  • TBBK $67.67
  • IOVA $23.06
  • AVG Volume (30 Days)
  • TBBK 535.7K
  • IOVA 7.3M
  • Earning Date
  • TBBK 01-30-2025
  • IOVA 02-26-2025
  • Dividend Yield
  • TBBK N/A
  • IOVA N/A
  • EPS Growth
  • TBBK 22.92
  • IOVA N/A
  • EPS
  • TBBK 4.29
  • IOVA N/A
  • Revenue
  • TBBK $495,381,000.00
  • IOVA $90,858,000.00
  • Revenue This Year
  • TBBK N/A
  • IOVA $13,803.28
  • Revenue Next Year
  • TBBK $8.21
  • IOVA $167.55
  • P/E Ratio
  • TBBK $13.59
  • IOVA N/A
  • Revenue Growth
  • TBBK 10.62
  • IOVA 12751.20
  • 52 Week Low
  • TBBK $29.92
  • IOVA $5.05
  • 52 Week High
  • TBBK $65.84
  • IOVA $18.33
  • Technical
  • Relative Strength Index (RSI)
  • TBBK 41.30
  • IOVA 44.96
  • Support Level
  • TBBK $59.57
  • IOVA $5.44
  • Resistance Level
  • TBBK $62.56
  • IOVA $5.80
  • Average True Range (ATR)
  • TBBK 2.27
  • IOVA 0.32
  • MACD
  • TBBK -0.62
  • IOVA 0.08
  • Stochastic Oscillator
  • TBBK 2.71
  • IOVA 65.77

About TBBK The Bancorp Inc

The Bancorp Inc is a financial holding company, through its subsidiary it is engaged in specialty lending namely securities-backed lines of credit, vehicle fleet and another equipment leasing, Small Business Administration lending, insurance policy cash value-backed lines of credit and commercial mortgage-backed loans, generated for sale into commercial mortgage-backed securities markets through securitizations. The company deposits and non-interest income are generated in the payments business which consists of issuing, acquiring, and automated clearing house accounts.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: